| RS34932849 |
RBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34937014 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS34937272 |
NRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS34937870 |
ABCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Dubin-Johnson syndrome, ABCC2-related disorder |
| RS34938432 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS34940368 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS34940801 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS34941422 |
FBN3
|
Health Risk |
Conflicting classifications of pathogenicity |
FBN3-related disorder, FBN3-related disorder |
| RS34942353 |
UGT1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lucey-Driscoll syndrome, Crigler-Najjar syndrome |
| RS34943572 |
MERTK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS34945623 |
HBB
|
Health Risk |
Pathogenic |
HEMOGLOBIN MADRID, Dominant beta-thalassemia |
| RS34946266 |
GNPTAB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS34946978 |
covers 10 genes, none of which curated to show dosage sensitivity
|
Health Risk |
Conflicting classifications of pathogenicity; other |
Hyperbilirubinemia, Lucey-Driscoll syndrome |
| RS34948328 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS34950075 |
NARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
NARS2-related disorder, NARS2-related disorder |
| RS34952009 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia 15 |
| RS34957318 |
SFTPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Surfactant metabolism dysfunction, pulmonary |
| RS34960334 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS34962745 |
HPS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 4, Oculocutaneous albinism |
| RS34963077 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS34966542 |
TNFRSF11A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive osteopetrosis 7, Paget disease of bone 2 |
| RS34966596 |
ETV6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS34968276 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS34969327 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS34969656 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, SLC6A1-related disorder |
| RS34972707 |
WNT10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Tooth agenesis, selective |
| RS34972863 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34973695 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyropoikilocytosis, hereditary |
| RS34975911 |
HBD
|
Health Risk |
Pathogenic |
delta Thalassemia, delta Thalassemia |
| RS34979623 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS34980264 |
HBB
|
Health Risk |
Pathogenic; other |
HEMOGLOBIN SAINT JACQUES, Erythrocytosis |
| RS34982899 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS34986638 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS34987997 |
CP
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of ferroxidase, Deficiency of ferroxidase |
| RS34988750 |
GJB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ichthyosis, hystrix-like |
| RS34989098 |
RTTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic primordial dwarfism due to RTTN deficiency, RTTN-related disorder |
| RS34993202 |
TIE1
|
Health Risk |
Pathogenic |
Lymphatic malformation 11, Lymphatic malformation 11 |
| RS34993780 |
UGT1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Crigler-Najjar syndrome, type II |
| RS34994927 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS34995376 |
LRRK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant Parkinson disease 8, Autosomal dominant Parkinson disease 8 |
| RS34995577 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
MBD5 associated neurodevelopmental disorder, Intellectual disability |
| RS34999029 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS34999973 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
BETA-PLUS-THALASSEMIA, beta Thalassemia |
| RS35001569 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS35001900 |
CLEC4F
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS35002004 |
GJB6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 3B, Hidrotic ectodermal dysplasia syndrome |
| RS35002351 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS35002698 |
HBB
|
Health Risk |
Pathogenic |
HEMOGLOBIN PIERRE-BENITE, Hemoglobinopathy |
| RS35003977 |
UGT1A1
|
Health Risk |
Conflicting classifications of pathogenicity; other |
Hyperbilirubinemia, Crigler-Najjar syndrome |
| RS35004053 |
NR2E3
|
Health Risk |
Pathogenic/Likely pathogenic |
Enhanced S-cone syndrome, NR2E3-related disorder |
| RS35004220 |
HBB
|
Health Risk |
Pathogenic/Likely pathogenic |
BETA-PLUS-THALASSEMIA, beta Thalassemia |
| RS35006579 |
SPINK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS35007621 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS35010099 |
CNGB3
|
Health Risk |
Likely pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS35013643 |
ITGB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS35016946 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, NEB-related disorder |
| RS35018134 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS35020585 |
HBB
|
Health Risk |
Pathogenic |
HEMOGLOBIN ANDREW-MINNEAPOLIS, Erythrocytosis |
| RS35021397 |
CFAP43
|
Health Risk |
Conflicting classifications of pathogenicity |
CFAP43-related disorder, CFAP43-related disorder |
| RS35026927 |
PYGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type VI |
| RS35027371 |
KCND3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Spinocerebellar ataxia type 19/22 |
| RS35029074 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS35031194 |
APC
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS35031397 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
WFS1-Related Spectrum Disorders, Monogenic diabetes |
| RS35031555 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary arterial hypertension, Inborn genetic diseases |
| RS35035518 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS35040971 |
GHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Laron-type isolated somatotropin defect, Laron-type isolated somatotropin defect |
| RS35045067 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS35045151 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, MSH3-related disorder |
| RS35051231 |
CARD9
|
Health Risk |
Conflicting classifications of pathogenicity |
Predisposition to invasive fungal disease due to CARD9 deficiency, Predisposition to invasive fungal disease due to CARD9 deficiency |
| RS35051256 |
GSS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inherited glutathione synthetase deficiency, Inborn genetic diseases |
| RS35051558 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS35051736 |
CYP24A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercalcemia, infantile |
| RS35055527 |
EPRS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS35057005 |
CACNA1D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS35058636 |
TRPV4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2C, Charcot-Marie-Tooth disease |
| RS35064500 |
NLRP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 2, Multisystem inflammatory syndrome in children |
| RS35067717 |
HBB
|
Health Risk |
Pathogenic; other |
HEMOGLOBIN HEATHROW, Erythrocytosis |
| RS35067805 |
P3H2
|
Health Risk |
Pathogenic |
— |
| RS35068180 |
MMP3
|
Health Risk |
risk factor |
Coronary heart disease, susceptibility to |
| RS35068278 |
MCCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylcrotonyl-CoA carboxylase 2 deficiency, Methylcrotonyl-CoA carboxylase deficiency |
| RS35068710 |
RTTN
|
Health Risk |
Conflicting classifications of pathogenicity |
RTTN-related disorder, RTTN-related disorder |
| RS35070204 |
SLC12A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS35072845 |
P3H2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS35077384 |
ZFYVE27
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 33, Spastic tetraparesis |
| RS35077871 |
DDR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome, Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome |
| RS35086265 |
NDUFS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 6 |
| RS35087111 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Kabuki syndrome |
| RS35087810 |
SMARCAL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schimke immuno-osseous dysplasia, Kidney disorder |
| RS35088381 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS35089233 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease due to ABCA3 deficiency, ABCA3-related disorder |
| RS35090700 |
CACNA1D
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, CACNA1D-related disorder |
| RS35092963 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures |
| RS35094910 |
DRC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS35095508 |
APRT
|
Health Risk |
Conflicting classifications of pathogenicity |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS35099082 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS35099769 |
TEP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS35101495 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Rothmund-Thomson syndrome type 2 |
| RS35102652 |
ACAN
|
Health Risk |
Conflicting classifications of pathogenicity |
ACAN-related disorder, Inborn genetic diseases |
| RS35103377 |
EVC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Curry-Hall syndrome, Ellis-van Creveld syndrome |